Clinical Trial Update: Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronic acid for bone involvement in metastatic breast cancer, metastatic prostate cancer, or multiple myeloma; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Multiple Myeloma
• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Adenocarcinoma, DS Stage I Plasma Cell Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2018-11-07